Azithromycin as Host-directed Therapy for Pulmonary Tuberculosis
NCT03160638
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Tuberculosis, Pulmonary
Interventions
DRUG:
Azithromycin 250 mg
Sponsor
University Medical Center Groningen